Natera (NTRA) revenue: $2.3B
Natera reported $2.3B of revenue for the year ended Dec 31, 2025, up 35.9% from $1.7B a year earlier.
From Natera's filings with the SEC · Read the filing · NTRA stock page
Natera revenue by year
#1,106 of 3,622 US companies by revenue · See the full ranking
| Year ended | Revenue | Change |
|---|---|---|
| Dec 31, 2025 | $2.3B | +36% |
| Dec 31, 2024 | $1.7B | +57% |
| Dec 31, 2023 | $1.1B | +32% |
| Dec 31, 2022 | $820M | +31% |
| Dec 31, 2021 | $625M | – |
Revenue of similar companies
Companies in the same industry as Natera, by SEC industry code, with the closest revenue. Each name opens the same page for that company.
| Company | Revenue, latest year | Year ended |
|---|---|---|
| Quest Diagnostics | $11B | Dec 31, 2025 |
| Fortrea | $2.7B | Dec 31, 2025 |
| Natera | $2.3B | Dec 31, 2025 |
| RadNet | $2B | Dec 31, 2025 |
| Guardant Health | $982M | Dec 31, 2025 |
| Caris Life Sciences | $812M | Dec 31, 2025 |
| Veracyte | $517M | Dec 31, 2025 |
Questions and answers
What is Natera's revenue?
Natera reported $2.3B of revenue for the year ended Dec 31, 2025, up 35.9% from $1.7B a year earlier.
Numbers as reported in Natera's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology